Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 831,900
Avg Vol 567,634
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 62%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 850 298 8866
Address:
3494 Martin Hurst Road, Tallahassee, United States
August_West
August_West Jul. 3 at 11:51 PM
$TRLV $TLRY Got an ounce of Modern Flower Gelonade for $99 today at the Trulieve dispensary. And it’s decent.
2 · Reply
Jonnny69
Jonnny69 Jul. 3 at 2:39 PM
0 · Reply
Jonnny69
Jonnny69 Jul. 3 at 4:17 AM
0 · Reply
JohnB72
JohnB72 Jul. 2 at 8:33 PM
$TRLV why did this pop hard today ?
2 · Reply
ackerman2436
ackerman2436 Jul. 2 at 8:19 PM
$MSOS Once again, I hate Tom Angell with a passion, but this article makes it pretty clear, the DOJ is 100% on the side of rescheduling. The train has officially left the station. It's not moving too quickly just yet, but it's not slowing down, and it's not stopping. $MSOX $TRLV https://www.marijuanamoment.net/doj-marijuana-lawsuit-filing-cites-drug-testing-industry-and-pharma-company-pocketbook-interests-in-opposing-rescheduling/
1 · Reply
Ro_Patel
Ro_Patel Jul. 2 at 7:27 PM
$TRLV CEO cancels her automatic personal sell plan In March 2026, she set up an Automatic Securities Disposition Plan (ASDP) under Rule 10b5-1 to sell 2.5M shares in 2 structured blocks (tranches) On June 9, 2026, the Board authorized a share repurchase program to repurchase up to the lesser of (i) $50M in aggregate value or (ii) 8,495,038 subordinate voting shares of the Company (5% of the Company's issued & outstanding subordinate voting shares as at June 8, 2026) over a 12-month period Back-of-napkin: If above $10/share then $50M buyback = 2.94% of shares repurchased
0 · Reply
jeffgosia6
jeffgosia6 Jul. 2 at 7:14 PM
0 · Reply
ackerman2436
ackerman2436 Jul. 2 at 7:07 PM
$MSOS $TRLV Is a $100 + stock in the making
1 · Reply
ackerman2436
ackerman2436 Jul. 2 at 6:57 PM
$MSOS $TRLV With a real nice move. Both holding their own on a red day for markets. There is no stopping what's coming $MSOX
0 · Reply
jeffgosia6
jeffgosia6 Jul. 2 at 3:26 PM
$TRLV of course I added too early 😜
1 · Reply
August_West
August_West Jul. 3 at 11:51 PM
$TRLV $TLRY Got an ounce of Modern Flower Gelonade for $99 today at the Trulieve dispensary. And it’s decent.
2 · Reply
Jonnny69
Jonnny69 Jul. 3 at 2:39 PM
0 · Reply
Jonnny69
Jonnny69 Jul. 3 at 4:17 AM
0 · Reply
JohnB72
JohnB72 Jul. 2 at 8:33 PM
$TRLV why did this pop hard today ?
2 · Reply
ackerman2436
ackerman2436 Jul. 2 at 8:19 PM
$MSOS Once again, I hate Tom Angell with a passion, but this article makes it pretty clear, the DOJ is 100% on the side of rescheduling. The train has officially left the station. It's not moving too quickly just yet, but it's not slowing down, and it's not stopping. $MSOX $TRLV https://www.marijuanamoment.net/doj-marijuana-lawsuit-filing-cites-drug-testing-industry-and-pharma-company-pocketbook-interests-in-opposing-rescheduling/
1 · Reply
Ro_Patel
Ro_Patel Jul. 2 at 7:27 PM
$TRLV CEO cancels her automatic personal sell plan In March 2026, she set up an Automatic Securities Disposition Plan (ASDP) under Rule 10b5-1 to sell 2.5M shares in 2 structured blocks (tranches) On June 9, 2026, the Board authorized a share repurchase program to repurchase up to the lesser of (i) $50M in aggregate value or (ii) 8,495,038 subordinate voting shares of the Company (5% of the Company's issued & outstanding subordinate voting shares as at June 8, 2026) over a 12-month period Back-of-napkin: If above $10/share then $50M buyback = 2.94% of shares repurchased
0 · Reply
jeffgosia6
jeffgosia6 Jul. 2 at 7:14 PM
0 · Reply
ackerman2436
ackerman2436 Jul. 2 at 7:07 PM
$MSOS $TRLV Is a $100 + stock in the making
1 · Reply
ackerman2436
ackerman2436 Jul. 2 at 6:57 PM
$MSOS $TRLV With a real nice move. Both holding their own on a red day for markets. There is no stopping what's coming $MSOX
0 · Reply
jeffgosia6
jeffgosia6 Jul. 2 at 3:26 PM
$TRLV of course I added too early 😜
1 · Reply
jeffgosia6
jeffgosia6 Jul. 2 at 2:41 PM
$TRLV just added here, averaging up a little actually...sick upside potential
0 · Reply
MOONEYMAN
MOONEYMAN Jul. 2 at 11:24 AM
0 · Reply
Winston_
Winston_ Jul. 2 at 8:47 AM
$TRLV $MSOS @EconomxGuru You need a better understanding of the difference in Federal and State cannabis laws/licensing, FDA system and how big Pharma makes such massive profits. The following was quickly found: Federal laws and strict testing rules stop pharmaceutical companies from selling natural cannabis. The U.S. Food and Drug Administration (FDA) requires all medicines to be pure, consistent, and proven to work through long studies. Because a raw cannabis plant is a mix of many chemicals, drug makers cannot easily test or patent it like a normal pill. Pharmaceutical companies make money by patenting new drugs. Natural cannabis is a plant, so drug makers cannot claim it as their own invention. To sell cannabis, pharmaceutical companies must either get traditional FDA approval for specific chemical compounds or wait for the federal government to fully legalize the plant. Until then, they focus on lab-created, patented alternatives.
1 · Reply
EconomxGuru
EconomxGuru Jul. 1 at 11:26 PM
$TRLV I dunno. If they’re selling it in pharmacies, why would you need a storefront? And when will big pharma just overpower with their pharm distribution channels? Has Tru peaked? It’s like a double edged sword.
1 · Reply
TRL1985
TRL1985 Jul. 1 at 7:54 PM
$TRLV enough of the good news it is destroying the stock lol please ban weed again so we can get 14$ because ”Biden and the democrats might do S3!” oh man! it might possibly happen one day! $14!! Now we have it on lockdown, new states onboard, better environment all around, DEA on our side and even have a real chance at deschedule and it’s struggling to break 10$. 🦧❓ I’m looking at this and thinking we might see $6 before we see $12. Anyways, holding and buying like a good little masochist
1 · Reply
CasinosOfferFreeDrinks
CasinosOfferFreeDrinks Jul. 1 at 7:18 PM
$CURLD $MSOS $GTBIF $TRLV $TLRY Yay Virginia! Better buy as much as you can, insiders and institutions are
3 · Reply
WallStreetPup
WallStreetPup Jul. 1 at 7:08 PM
$TRLV https://apnews.com/article/marijuana-cannabis-legal-sales-virginia-weed-shops-7da81e3fe8d50f7ea37262a04015e4dc
0 · Reply
DocMP
DocMP Jul. 1 at 4:26 PM
$HITI king of Canada $TRLV $GTBIF Three kings of cannabis 💎 🖐️ 🤴 🤴 🤴
2 · Reply
Biggaps
Biggaps Jul. 1 at 3:47 PM
I am excited for $SNDL to close on Parallel officially in the next couple of weeks. Also glad they still own a good stake of undervalued $HITI , great company too. That saying once officially an MSO this summer and can consolidate Florida and Texas financials, I think we will start to close in on evaluations similar to $TRLV and $GLASF with a market cap of atleast 1 billion.
2 · Reply
Winston_
Winston_ Jul. 1 at 2:32 PM
$MSOS $TRLV 😎 https://www.nasdaq.com/press-release/trulieve-commemorates-georgia-medical-cannabis-launch-first-sale-2026-07-01
1 · Reply
FuggNMoney
FuggNMoney Jul. 1 at 12:06 PM
$SNDL $MSOS $ACB $TRLV WELCOME TO Q3. SHORTS BEWARE!!!
0 · Reply
HSR_Stocks
HSR_Stocks Jul. 1 at 2:01 AM
$MSOS $TRLV $CURLD $GTBIF the lack of news coverage on the rescheduling hearing is truly astonishing. Not one thing from cnbc that I can find
1 · Reply